Tag Archives: Alzheimers

Latest Early Onset Alzheimers News

September 13, 2012     No comments

Concordia University study zeroes in on early signs of Alzheimer's
Prevention may really be the cure when it comes to Alzheimer's disease, and a study from Concordia University has identified a new way of detecting the disease early — and potentially helping to fight Alzheimer's before its onset. The study might also …
Read more on Montreal Gazette

FAMILIAL BONDS / Story of father and daughter's struggle
The story centers on the character of Keisuke Kinoshita (Toyokawa), who suffers from early-onset Alzheimer's, and his daughter Miu (Ashida), who is a second-grade primary school student. The father, a good-hearted metal processing factory employee, is …
Read more on The Daily Yomiuri

Alzheimers creeps in often unnoticed
… creeps in often unnoticed. Kiri Gillespie | Monday, September 3, 2012 10:13. September is World Alzheimer's Month and former Tauranga branch manager Jane Moore said the organisation's main concern was identifying people with early onset dementia.
Read more on The Bay of Plenty Times

Caregivers, advocates say National Alzheimer's Plan needs to help patients now
Laura Jones, of Lighthouse Point, had a 3-year-old daughter when her husband, Jay, was diagnosed with early-onset Alzheimer's at age 50, and she eventually was forced to move her husband to a care facility. In the past year, Jones said, she's lost her …
Read more on Sun-Sentinel

Read More

Latest Alzheimers News

September 03, 2012     No comments

Weekend events net G for Alzheimer's
A weekend walk and clambake in downtown Riverhead raised more than $ 30,000 for Alzheimer's disease research, with a crowd of more than 200 people walking down East Main Street, starting at Grangebel Park and ending at the Long Island Aquarium.
Read more on Newsday (blog)

Dance classes aim to help patients with Alzheimer's disease, other dementia
LinkedIn; Tumblr; StumbleUpon; Reddit; Del.icio.us; Digg. A; A. Tap Dancing with Alzheimer's: Tap dancer Mary Archer shares her love of tap dancing and music with dementia and Alzheimer's patients at Vista Cove assisted living facility in Rancho Mirage.
Read more on The Desert Sun

Read More

Latest Alzheimers News

August 12, 2012     No comments

Benefit fête in Wellfleet to fight Alzheimer's
The Wellfleet Alzheimer's Association will hold its 11th annual reception and charity auction from 3 to 7 p.m. Sunday, Aug. 12 at Sweet Seasons at the Inn at Duck Creeke in Wellfleet. There will be wine, elegant nibbles and entertainment by the band …
Read more on Wicked Local

Medicare won't need to be "saved" as chronic diseases become preventable
The number of new patients diagnosed with Alzheimer's disease is increasing, but Alzheimer's-related mortality is decreasing. Together, these trends account for the predicted increase in the number of people living with Alzheimer's from 5 million today …
Read more on Democratic Underground

Parents can now screen their embryos for Alzheimer's so they can have babies …
But neuroscientist Professor John Hardy, of University College London, an expert in the genetic causes of Alzheimer's, said: 'I'm so happy the HFEA has done this. It means families will be free of this scourge for all future generations and will really …
Read more on Daily Mail

Read More

Amyloid Beta Level in Serum Predicts Risk for Vascular Disease in First-Degree Relatives of Alzheimer?s Patients

July 30, 2012     No comments

Manhasset, NY (Vocus) February 6, 2009

People with a family history of Alzheimer?s disease, who have high levels of amyloid beta (A?) in the serum, are at increased risk for vascular disease. These heightened A? levels may predict whether those without symptoms may progress towards dementia in years to come.

Michael Mullan, MD, and his colleagues at the Roskamp Institute in Sarasota, Fl., collaborated with statisticians at the London School of Hygiene and Tropical Medicine to see if elevated levels of A? in the blood in first-degree relatives of Alzheimer?s patients are associated with risk factors for vascular disease. Recent studies have shown that vascular disease is a major risk factor for Alzheimer?s. They recruited 197 local study subjects from the Alzheimer?s Disease Anti-Inflammatory Prevention Trial, which included unaffected family members, as well as 98 community elders in Florida. They studied the association of amyloid beta levels in serum with risk factors for vascular disease, including total cholesterol, LDL, HDL, systolic blood pressure, diastolic blood pressure and serum creatinine. They also looked at medications prescribed for vascular disease or the risk factors associated with vascular disease.

A? in serum is used as a marker to predict A? accumulation in the brain, which is one of the key pathologies of Alzheimer?s. In this study, the scientists found A? levels were significantly higher in first-degree relatives of Alzheimer?s patients, as compared with the elder community controls. The scientists say they suspect this elevation may be ?indicative of increased amyloid beta production due to genetic and/or other risk factors.?

?These findings suggest that an increased risk of Alzheimer?s disease associated with family history may be mediated in part through the enrichment of individuals with vascular risk factors and may be reflective of pre-symptomatic Alzheimer?s disease pathology,? Dr. Mullan and his colleagues wrote.

In another stunning finding in the same issue of Molecular Medicine, scientists from Virginia Commonwealth University, Northwestern University, UCSF, UCLA, University of Pennsylvania, and University of North Carolina, identified a genetic signature for a hepatitis C virus-induced liver cancer, and different genetic handprints for cirrhosis caused by hepatitis C. They were able to use these genetic signatures to distinguish between pathological stages of liver cancer and early disease states, suggesting a way to diagnose this hepatocellular carcinoma earlier in the disease process.

Molecular Medicine is published by The Feinstein Institute for Medical Research, part of the North Shore-LIJ Health System. For more information on the study, visit http://www.molmed.org or contact Veronica J. Davis. Free podcasts from the latest issue of Molecular Medicine are also available on the journal?s web site and in iTunes.

###







Related Carcinoma Press Releases

Read More

Study Reveals Top Non-genetic Risk Factors for Alzheimer?s and Parkinson?s, Reports DoctorsHealthPress.com

July 30, 2012     No comments


Boston, MA (PRWEB) July 10, 2012

The Doctors Health Press, a publisher of various natural health newsletters, books, and reports, including the popular online Doctors Health Press e-Bulletin, reports on an on-going study on the top risk factors of Alzheimer?s.

As reported in Doctors Health Press e-Bulletin (http://www.doctorshealthpress.com/brain-function-articles/the-top-risk-factors-for-alzheimers-revealed), over the past decade, medical professionals and scientists have been searching for any clues that show links between disease and environmental toxins. While some diseases are definitely caused by genetic factors, many others have simply baffled doctors. Alzheimer?s disease and Parkinson?s disease fall into this category. A lot has been learned about what happens when someone gets either of these medical conditions, but not a lot is known about what triggers them and causes them to take hold in the body in the first place.

The Doctors Health Press e-Bulletin article reports scientists generally agree that there is unlikely a single clear cause of Alzheimer?s. For this reason, many suggest Alzheimer?s is the result of a combination of inter-related factors, including genetic factors and environmental influences that could include anything from previous head trauma to educational level, to experiences early in life. A new growing body of research is also helping to identify various ?lifestyle factors,? such as dietary habits, high blood pressure, high cholesterol, and exposure to environmental toxins.

As for Parkinson?s, scientists know that the brain cells that control movement rely on a chemical called ?dopamine.? Dopamine is manufactured in an area of the brain called the substantia nigra. In Parkinson?s, dopamine-producing cells in the substantia nigra are lost. In most cases, no one knows why. Some genetic mutations have been discovered, suggesting that Parkinson?s may run in some families; however, new clinical trials are suggesting that environment plays a larger role than inheritance. In fact, the general medical consensus is that genetic factors are dominant only in Parkinson?s that appears before age 50.

So what?s really happening to usher in these two diseases? For some answers, consider the results from a recent clinical trial performed by Spanish researchers. These scientists decided to conduct a review to find which risk factors were most prominent when it came to Alzheimer?s or Parkinson?s. Here are the results, as the Doctors Health Press e-Bulletin article, ?The Top Risk Factors for Alzheimer?s Revealed,? reports:


????Evidence consistently suggests that a higher risk of Parkinson?s is associated with pesticides.
????A higher risk of Alzheimer?s is associated with pesticides, hypertension, high cholesterol levels in middle age, and high levels of homocysteine, smoking, traumatic brain injury, and depression.
????There is some evidence suggesting that higher risk of Parkinson?s is associated with high milk consumption in men, high iron intake, chronic anemia, and traumatic brain injury.
????There is also some evidence suggesting a higher risk of Alzheimer?s is associated with high aluminum intake through drinking water, excessive exposure to electromagnetic fields from electrical grids, obesity in middle age, excessive alcohol consumption, and chronic anemia.

(SOURCE: Campdelacreu, J., “Parkinson disease and Alzheimer disease: environmental risk factors,” Journal Neurologia, June 13, 2012.)

Doctors Health Press e-Bulletin is a daily e-letter providing natural health news with a focus on natural healing through foods, herbs and other breakthrough health alternative treatments. For more information on Doctors Health Press, visit http://www.doctorshealthpress.com.

The Doctors Health Press believes in the healing properties of various superfoods, like pistachios, as well as the benefits of taking vitamins and supplements, Chinese herbal remedies and homeopathy. To see a video outlining the Doctors Health Press’ views on homeopathic healing, visit http://www.doctorshealthpress.com/homeopathy.







More Depression Press Releases

Read More

Stemedica International And Academic Partner Awarded Swiss Alzheimer?s And Stem Cell Research Grant

July 08, 2012     No comments


Epalinges, Switzerland (PRWEB) May 24, 2012

Stemedica International, Epalinges, Switzerland, a wholly owned subsidiary of Stemedica Cell Technologies, Inc. (San Diego, CA) announced today that it was awarded a grant by the Swiss Commission for Technology and Innovation along with its academic partner, The ?cole Polytechnique F?d?rale de Lausanne (EPFL). The 584,522 CHF (approx. 620,000 USD) grant is focused on the use of EPFL?s advanced imaging capabilities along with Stemedica?s ischemic tolerant stem cells and stem cell factors in transgenic mouse models of Alzheimer?s disease. The basic research supports Stemedica?s clinical trial advancement for Alzheimer?s disease for both Switzerland and the United States.

?We are pleased that we will be collaborating with one of the world?s leading technical academic institutions,? said Nikolai Tankovich, MD, PhD, Executive Chairman of Stemedica International. ?We will be able to see the therapeutic potential of our ischemia tolerant neural and mesenchymal cells, as well as the impact of our stem cell factors on the amyloid plaque pathology and brain vascularization associated with Alzheimer?s disease. ?

EPFL has developed sophisticated imaging methods that allow for the visualization of amyloid plaques without the need of injecting amyloid-binding dyes / contrast agents. In addition to visualizing amyloid plaques, the precise, femtosecond laser system allows imaging of quantitative blood flow and other critical functional parameters.

Professor Theo Lasser, Head of Laboratoire d?Optique Biomedicale (LOB), EPFL, commented, ?We are excited to collaborate with the world?s leading manufacturer of allogeneic stem cells and apply our methods of Optical Coherent Microscopy developed at LOB, EPFL to potentially find a cure for Alzheimer?s disease. ?

Tristan Bolmont, PhD, of EPFL will lead the research project, along with Alexei Lukashev, PhD., Director of the Laser Stem Cell Division, Stemedica. Dr. Bolmont commented on the scope of the project, ?The scale of this project, treating and imaging more than 140 subjects, will allow us to make the correlations that are critical to understanding the pathophysiology of this disease. Furthermore, we will better understand the biodistribution and the mechanism of action of Stemedica?s ischemia tolerant neural and mesenchymal stem cells and how they affect the Alzheimer?s altered brain.?

According to Roger Howe, PhD, President of Stemedica International, ?The Swiss government is being remarkably progressive in bridging the gap between bench top research and translational medicine. We greatly appreciate their support in documenting stem cell effectiveness in neurological diseases.?

For more information please contact Dave McGuigan at dmcguigan (at) stemedica.com

About Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies, Inc. is a specialty bio-pharmaceutical company committed to the manufacturing and development of best-in-class allogeneic adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government licensed manufacturer of clinical grade stem cells and is approved by the FDA for its clinical trials for ischemic stroke. Stemedica is currently developing regulatory pathways for a number of medical indications using adult allogeneic stem cells. The Company is headquartered in San Diego, California.

About The ?cole Polytechnique F?d?rale de Lausanne (EPFL)

The EPFL is one of the two Swiss Federal Institutes of Technology is located in Lausanne, Switzerland. The school was founded by the Swiss Federal Government with the stated mission to (a) educate engineers and scientists, (b) be a national center of excellence in science and technology, (c) provide a hub for interaction between the scientific community and industry. The sister institution in the German-speaking part of Switzerland is the Eidgen?ssische Technische Hochschule Z?rich (ETH Z?rich or ETHZ). Associated with several specialized research institutes, the two sister institutes form the ETH Domain. EPFL is ranked among the top academic institutions in the world.







Find More Alzheimers Press Releases

Read More

MetLife Foundation Recognizes Alzheimer’s Disease Research with Prestigious Awards

June 20, 2012     No comments


New York, New York (PRWEB) May 15, 2012

MetLife Foundation today announced the recipients of its 2012 Awards for Medical Research in Alzheimer?s Disease: Clifford R. Jack Jr., M.D., professor of Radiology and The Alexander Family Professor of Alzheimer?s Disease Research at Mayo Clinic (Rochester, MN), and Christine Van Broeckhoven, Ph.D. D.Sc., professor and department director of the VIB Department of Molecular Genetics at the University of Antwerp (Belgium). In addition, Randall J. Bateman, M.D., associate professor of Neurology at the Washington University School of Medicine in St. Louis, is recipient of MetLife Foundation?s Promising Investigator Award.

Dr. Jack, an innovator in clinical studies of brain structure in disease, developed and applied imaging methodologies to determine and track the stages of Alzheimer?s disease. Dr. Van Broeckhoven, a basic scientist and expert in molecular genetics, has made groundbreaking discoveries establishing the genetic basis of inherited Alzheimer?s disease and related disorders. Dr. Bateman, a neurologist and biochemist, has pioneered the use of measurements of beta-amyloid protein in the brain to better understand the biochemical basis of this illness.

The winners were recognized at a scientific briefing and awards ceremony today in New York.

?MetLife Foundation is proud to present these awards that recognize outstanding achievements in medical research,? said Dennis White, president and chief executive officer, MetLife Foundation. ?Doctors Jack, Van Broeckhoven and Bateman have made significant contributions to our understanding of Alzheimer?s disease and their dedication helps bring us closer to finding a cure for Alzheimer?s disease.?

About the Awards

Now in their 26th year, the awards provide outstanding researchers with an opportunity to freely pursue new ideas. At the heart of the program is a belief in research as the road to understanding and ultimately treating this devastating disease. Each major award recipient receives a $ 200,000 research grant for his or her institution to further their work, and a personal prize of $ 50,000. The recipient of the Promising Investigator Award receives a $ 100,000 grant to his institution to further his work in Alzheimer?s disease. MetLife Foundation established the awards in 1986 to recognize and reward scientists demonstrating significant contributions to the understanding of Alzheimer?s disease.

The MetLife Awards for Medical Research in Alzheimer?s Disease are managed by the American Federation for Aging Research (AFAR). Founded in 1981, AFAR has championed the cause and supported the funding of science in healthier aging and age-related medicine.

?We have selected these individuals because of their novel and significant approaches to Alzheimer?s disease, which are paving the way for additional discoveries that are important for diagnosis and treatments for this disease,? said Donald L. Price, M.D., chair of the MetLife Awards for Research in Alzheimer?s Disease Advisory Committee, which selected the winners. Dr. Price, professor of Pathology, Neurology and Neuroscience, Johns Hopkins School of Medicine, is a previous recipient of the MetLife Award.

According to recent estimates by the Alzheimer?s Association, the number of Americans aged 65 and older with Alzheimer?s disease will reach 16 million by 2050. Alzheimer?s costs related to health care and long-term care services are expected to total $ 200 billion this year.

Significant Discoveries That Have Shaped the Field

Drs. Jack, Van Broeckhoven and Bateman have made significant discoveries that have clarified our understanding, shaped new approaches to the disorder, and changed our view of Alzheimer?s disease.

Dr. Jack is a pioneer in developing medical imaging methods that identify biomarkers for Alzheimer?s disease. Identification and validation of biomarkers ? characteristics that measure a biological state, such as a stage of disease ? is a major objective in understanding and developing treatments for this disease. Starting in the early 1990s, Dr. Jack introduced imaging methods to help delineate manifestations of the disease in the brain, assess its severity, measure disease progression, and make predictions regarding its future course. These concepts have been widely adopted. Dr. Jack?s initial studies focused on a type of brain imaging known as anatomic MRI, but he has also contributed pioneering work in other areas including MR spectroscopy, diffusion imaging, functional MRI, high field microimaging, and amyloid PET analyses of amyloid burden.

He has integrated information from measures of biomarkers for the disease, derived from studies of central nervous system imaging and levels of markers in cerebrospinal fluid, into a comprehensive model of brain abnormalities in parallel with clinical features. The staging of presymptomatic (preclinical) Alzheimer?s disease in recently published National Institute on Aging-Alzheimer?s Association criteria was based largely on his model.

Dr. Van Broeckhoven is a leader in the molecular genetics of Alzheimer?s disease and other complex neurological and psychiatric disorders. Her research has established critical features of the genetic basis of different types of dementia. Nearly 30 year ago, she identified the gene encoding APP (amyloid precursor protein), the first gene linked to familial Alzheimer?s disease. She and her colleagues demonstrated the involvement of the brain?s blood vessels in the neurodegenerative process. She helped identify the presenilin-1 gene on chromosome 14 as an additional gene involved in inherited cases of Alzheimer?s disease and contributed important information on the role of apolipoprotein E4, a protein that binds blood lipids, as a risk factor for both late-onset and early-onset Alzheimer?s disease.

Dr. Van Broeckhoven?s most recent work has focused on the genetics of other neurodegenerative diseases. She and her colleagues identified the gene that encodes the protein progranulin, an observation that provided the first evidence that growth factors play a major role in neurodegeneration in certain types of dementia.

Dr. Bateman has pioneered the use of Stable Isotope Labeling Kinetics (SILK) measurements of these disease markers in cerebrospinal fluid. Using this method, he has shown that people with Alzheimer?s do not properly eliminate amyloid-beta ? the protein that builds into plaques in the brains of those with Alzheimer?s ? from the brain as well as those without the disease. With a primary focus on the ways in which the disease changes the brain?s functional properties ? in order to develop better diagnostic and treatment strategies ? his lab has begun to study additional Alzheimer?s related proteins and their potential roles in the disease process.

In addition to conducting clinical trials, Dr. Bateman is director of the Therapeutic Trials Unit of the Dominantly Inherited Alzheimer?s Network, the largest international study of autosomal dominant Alzheimer?s disease. He has led efforts to make effective experimental treatments available to people with this hereditary form of the illness, with the goal of preventing clinical dementia before cognitive impairments are evident.

For additional background on the award recipients, visit: http://www.afar.org/research/MLF-awards

About MetLife Foundation

MetLife Foundation was established in 1976 by MetLife to carry on its long tradition of corporate contributions and community involvement. For over 25 years, MetLife and MetLife Foundation have invested more than $ 20 million for Alzheimer’s research and public information programs, including over $ 13 million through the Awards for Medical Research in Alzheimer?s Disease program. The Foundation has also supported a number of major initiatives, including the PBS documentary The Forgetting: A Portrait of Alzheimer?s; short pocket films on Alzheimer’s narrated by David Hyde-Pierce; an educational initiative with the National Institute on Aging?s Alzheimer?s Disease Centers; the film Alzheimer?s Disease: Facing the Facts; and initiatives that include caregiving videos, Alzheimer’s toolkits and resources for the Hispanic community.







Related Alzheimers Press Releases

Read More

Senior Helpers Report Majority of Americans Polled Fail National Alzheimer?s Quiz

June 19, 2012     No comments


Towson, MD (PRWEB) May 11, 2012

It may hit the siblings when visiting mom this Mother?s Day. She?s not as sharp as she used to be – very forgetful and confused. Is it old age or Alzheimer?s? The realization that not much is known about the disease can be worrisome.

Half of all Americans know someone with Alzheimer?s, the deadly disease that affects five million people – more women than men. Yet in a recent Senior Helpers National Alzheimer?s Quiz taken by more than one thousand Americans, 67% or 2/3 failed (they got fewer than 60% of the questions correct).

That?s why Senior Helpers, one of the nation?s largest providers of in-home senior care, has launched Senior Gems, a free and revolutionary Alzheimer?s education program that assigns each stage of the disease to a gem, like a diamond or ruby, and gives step-by-step instruction so people can navigate every mood and movement of a loved one trying to cope through the various stages of the disease. Readers/viewers can get a free DVD that walks them through the Senior Gems program by visiting http://www.seniorhelpers.com.

?We have a crisis in America because Alzheimer?s is a deadly epidemic yet this quiz shows many people still don?t know enough about the disease or how to best communicate with a loved one who has it. As our population grows older and lives longer, families will need survival skills to cope through the vicious cycles of the disease and manage the stressful toll it takes on everyone,? says Peter Ross, CEO and founder of Senior Helpers, one of the nation?s largest in-home senior care companies and co- creator of the Senior Gems program. ?We launched Senior Gems to give caregivers and family members a hands-on guide for education and survival.?

Pam?s Mother?s Day Heartbreak

Pam Huntoon from Twin Cities, Minnesota says she didn?t know much about Alzheimer?s disease until her 85-year-old mother was diagnosed. ?You suddenly do a ton of research but that doesn?t teach you how to handle the person in real life situations,? she says. ?Mom used to be witty and sharp with a great sense of humor. Now she has hallucinations and she?s very confused. It?s a struggle.?

Pam watched the Senior Gems DVD and hired a Senior Helper?s caregiver trained in Gems to help with her mom five days a week. ?It has been such a blessing to have this help. I?ve learned it?s not Mom?s fault that she acts this way that she can?t help herself. I can?t argue or prove my point. Gems has taught me to be patient and kind and that has been a lifesaver as we guide Mom through this final stage of her life.?

To Tell This Story:

Print the quiz in its entirety so the audience can take the quiz and see how they stack-up.
Please provide a link so the audience can receive a free DVD of the Senior Gems program. The audience can also learn the difference between normal aging and Alzheimer?s by visiting http://www.seniorhelpers.com.

*Editor?s Note: Please cite Senior Helpers as the source for this quiz.

*This online quiz was given by a third party, commissioned by Senior Helpers.

*The survey included 1,013 respondents: male and female, 40 years or older, with a living parent. Full survey data available upon request.

About Senior Helpers:

Senior Helpers connects professional caregivers with seniors who wish to live at home as opposed to a nursing or assisted living facility. The company has 300 franchises in 39 states and one in Canada offering a wide range of personal and companion care services to assist seniors living independently with a strong focus on quality of life for the client and peace of mind for their families. Senior Helpers strives to be the leading companion and personal care provider that offers dependable, consistent and affordable home care. For more information, please visit http://www.seniorhelpers.com

About Senior Gems:

Senior Gems is a revolutionary program to help family members and professional caregivers properly care for their aging loved ones through each stage of dementia. Teepa Snow began developing her Gem Levels in 2006. In 2011, the Senior Gem program was created with her guidance and assistance. This program puts Senior Helpers at the forefront of individual and in-home dementia-specialized care giving as they offer all of their in-home companions and caregivers the opportunity to become dementia care certified through the training program.







More Alzheimers Press Releases

Read More

Training for Alzheimer?s Disease or Other Dementias: Home Instead Senior Care Network?s Groundbreaking Training Program Focuses on Coping with Difficult Behaviors

June 11, 2012     No comments


Omaha, NE (PRWEB) May 09, 2012

This caregiver ? whose spouse has Alzheimer?s disease ? describes the frustration and confusion that grips families whose seniors are dealing with the symptoms of Alzheimer?s disease and other dementias.

The characteristics of these diseases are varied and change with time, but often leave families and their caregivers frightened and ill-equipped while they try to provide at-home care for their seniors.

A new groundbreaking training program now offers help for the many families who are dealing with challenging behaviors including refusal, delusions (or false beliefs), aggression, false accusations, wandering and agitation.

The Alzheimer?s Disease or Other Dementias CARE: Changing Aging Through Research and Education(SM) Training Program takes away some of the dread associated with these diseases. The no-cost program, which is available to families through their local Home Instead Senior Care? office, provides an innovative approach that helps families make the most of a senior?s life journey. The unique approach includes the history, passions and hobbies of the person with Alzheimer?s disease to help manage challenging behaviors associated with dementias.

?CARE is a wonderful hands-on approach that helps caregivers deal with the behavioral changes that too often accompany these disorders ? one of the biggest stressors for caregivers,? said Dr. Jane F. Potter, chief of the Division of Geriatrics and Gerontology at the University of Nebraska Medical Center. ?There was previously no good program available using adult education techniques to provide hands-on practice in learning how best to help people who suffer from dementia. This is huge.?

Resources of the Alzheimer?s Disease or Other Dementias CARE Training Program can help family caregivers understand Alzheimer?s disease and the changes they can expect to see in their loved ones. With the increased knowledge of Alzheimer?s and how to deal with it, family caregivers will be better able to cope with the stress of their responsibilities.

Local Home Instead Senior Care offices can provide even more information about making the most of living with Alzheimer?s and other dementias, giving caregivers hope for a brighter future. Too often, a family caregiver can become overwhelmed ? physically and mentally ? with providing in-home care and can see a slide in his or her health.

This CARE Family Caregiver Training Program is the same curriculum that is being offered to professional Home Instead CAREGiversSM. While providing respite services to families, Home Instead CAREGivers are trained to maintain a safe environment, encourage engagement, provide nutritious meals, offer supervision of medications, make trips to pharmacies for prescription refills, create social interaction, deliver mind-stimulating activities, provide transportation for medical appointments and supervise and assist with activities of daily living.

The CARE Family Caregiver Training Program is being offered by local Home Instead Senior Care offices throughout the country or through a self-guided online e-learning course.

ABOUT HOME INSTEAD SENIOR CARE

Founded in 1994 in Omaha by Lori and Paul Hogan, the Home Instead Senior Care? network is the world’s largest provider of non-medical in-home care services for seniors, with more than 950 independently owned and operated franchises providing in excess of 45 million hours of care throughout the United States, Canada, Japan, Portugal, Australia, New Zealand, Ireland, the United Kingdom, Taiwan, Switzerland, Germany, South Korea, Finland, Austria, Italy, Puerto Rico and the Netherlands. Local Home Instead Senior Care offices employ more than 65,000 CAREGivers(SM) worldwide who provide basic support services ? assistance with activities of daily living (ADLs), personal care, medication reminders, meal preparation, light housekeeping, errands, incidental transportation and shopping ? which enable seniors to live safely and comfortably in their own homes for as long as possible. In addition, CAREGivers are trained in the network?s groundbreaking Alzheimer?s Disease or Other Dementias CARE: Changing Aging Through Research and Education(SM) Program to work with seniors who suffer from these conditions. This world class curriculum also is available free to family caregivers online or through local Home Instead Senior Care offices. At Home Instead Senior Care, it?s relationship before task, while continuing to provide superior quality service that enhances the lives of seniors everywhere.

Additional information is available from Erin Albers, local PR and marketing director, and from Home Instead Senior Care?s online press kit.







Find More Mental Disorders Press Releases

Read More

Wearing Orange Glasses in the Evening to Maximize Melatonin May Help Avoid Alzheimer?s Disease

June 05, 2012     No comments

University Heights, OH (PRWEB) May 07, 2012

In recent papers from Italy, Russia and the US, scientists have described the possible benefits of melatonin in avoiding and treating Alzheimer?s disease. Wearing special glasses that block the blue light known to suppress melatonin allows it to flow as if in darkness. In this way the glasses available at LowBlueLights.com allow the body to produce melatonin for the 11-12 hours known to be possible. Because of exposure to light in the hours before bedtime, most Americans only make melatonin for 7 or 8 hours a night.

A recent study(1) of the spinal fluid that bathes the brain suggests this difference in the time that the pineal gland makes melatonin (and other antioxidants) may reduce the probability for the formation of the plaques (2) associated with Alzheimer?s disease. Studies in animals and humans show that the concentration of melatonin in the spinal fluid is significantly higher than in the blood. Melatonin is thought to be the unique antioxidant that protects the brain from damage by eliminating the free radicals that can damage the brain cells.

For information contact Richard L. Hansler PhD 216 397 1657 or rhansler(at)jcu(dot)edu.

(1)

Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system. PMID: 21358967 [Pubmed

(2)

Anti-amyloidogenic and anti-apoptotic role of melatonin in Alzheimer disease.PMID: 21358971 [PubMed







Find More Alzheimers Press Releases

Read More
« Older posts
Powered by WordPress | Designed by: best suv | Thanks to toyota suv, infiniti suv and lexus suv